Spotlight on microRNAs in allergy and asthma

J Weidner, S Bartel, A Kılıç, UM Zissler, H Renz… - Allergy, 2021 - Wiley Online Library
In past 10 years, microRNAs (miRNAs) have gained scientific attention due to their
importance in the pathophysiology of allergic diseases and their potential as biomarkers in …

MicroRNA regulation of RNA virus replication and pathogenesis

DW Trobaugh, WB Klimstra - Trends in molecular medicine, 2017 - cell.com
microRNAs (miRNAs) are non-coding RNAs that regulate many processes within a cell by
manipulating protein levels through direct binding to mRNA and influencing translation …

The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19

H Tang, Y Gao, Z Li, Y Miao, Z Huang… - Clinical and …, 2020 - Wiley Online Library
Background COVID‐19 is currently a global pandemic, but the response of human immune
system to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection …

[HTML][HTML] COVID-19 virulence in aged patients might be impacted by the host cellular microRNAs abundance/profile

S Fulzele, B Sahay, I Yusufu, TJ Lee, A Sharma… - Aging and …, 2020 - ncbi.nlm.nih.gov
The World health organization (WHO) declared Coronavirus disease 2019 (COVID-19) a
global pandemic and a severe public health crisis. Drastic measures to combat COVID-19 …

SOCS proteins participate in the regulation of innate immune response caused by viruses

S Huang, K Liu, A Cheng, M Wang, M Cui… - Frontiers in …, 2020 - frontiersin.org
The host immune system has multiple innate immune receptors that can identify, distinguish
and react to viral infections. In innate immune response, the host recognizes pathogen …

Exosome therapeutics for COVID‐19 and respiratory viruses

KD Popowski, PUC Dinh, A George, H Lutz, K Cheng - View, 2021 - Wiley Online Library
Respiratory viral diseases are a leading cause of mortality in humans. They have proven to
drive pandemic risk due to their complex transmission factors and viral evolution. However …

The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection

J Hu, J Stojanović, S Yasamineh, P Yasamineh… - Archives of …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). To date, there is no effective therapeutic approach …

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

N Chen, B Zhang, L Deng, B Liang… - Emerging microbes & …, 2022 - Taylor & Francis
ABSTRACT Currently, SARS-CoV-2, especially the Omicron strain, is ravaging the world
and even co-infecting human beings with IAV, which is a serious threat to human public …

Nucleic acid-based therapy for coronavirus disease 2019

R Piyush, K Rajarshi, A Chatterjee, R Khan, S Ray - Heliyon, 2020 - cell.com
Abstract The coronavirus disease 2019 (COVID-19), the pandemic that originated in China
has already spread into more than 190 countries, resulting in huge loss of human life and …

MicroRNAs and long non-coding RNAs as potential candidates to target specific motifs of SARS-CoV-2

L Natarelli, L Parca, T Mazza, C Weber, F Virgili… - Non-coding RNA, 2021 - mdpi.com
The respiratory system is one of the most affected targets of SARS-CoV-2. Various therapies
have been utilized to counter viral-induced inflammatory complications, with diverse success …